Cipralisant GT-2331|cas:213027-19-1|西域试剂

Cipralisant GT-2331,99.26%

产品编号：Bellancom-106993| CAS NO：213027-19-1| 分子式：C₁₄H₂₀N₂| 分子量：216.32

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，

货号	包装	价格	库存与货期	购买量	操作
Bellancom-106993		￥9000.00	杭州北京（现货）
Bellancom-106993		￥14500.00	杭州北京（现货）

增值税发票√顺丰快递√订货电话：18601927057

Cipralisant GT-2331

产品介绍

Cipralisant (GT-2331) 在体内是一种具有口服活性、低毒、有效、选择性、高亲和力的 histamine H3 receptor 的拮抗剂，在体外是 histamine H3 receptor 的激动剂，对于histamine H3 receptor，其 pK_i为 9.9，对大鼠 histamine H3 receptor 的K_i为 0.47 nM。Cipralisant 有研究注意缺陷多动障碍的潜力。

生物活性

Cipralisant (GT-2331) is an orally active, low-toxicity, potent, selective, high affinity histamine H3 receptor full antagonist in vivo, and an agonist in vitro, with a pK_i of 9.9 for histamine H3 receptor and a K_i of 0.47 nM for rat histamine H3 receptor. Cipralisant has the potential for attention-deficit hyperactivity disorder research^[4].

体外研究

Cipralisant behaves as a full agonist on adenylyl cyclase inhibition. Cipralisant (HEK cells) potently inhibits forskolin-induced cAMP accumulation, showing that Cipralisant works as a potent full histamine H3 receptor agonist. Cipralisant increases the basal [³⁵S]GTPγS binding activities in membranes from HEK cells expressing the rat histamine H3 receptor (EC₅₀, 5.6 nM).

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

Cipralisant (0.3~30 mg/kg; s.c.) enhances acquisition over five trials, reaching significance at 1 mg/kg.
Cipralisant (10 mg/kg; p.o.) completely blocks R-α-methylhistamine-induced drinking.
Cipralisant promotes wakefulness in the rat. Cipralisant potently and significantly improves performance in the repeated acquisition model, in line with its high affinity for the rat H3 receptor and good CNS penetration. Cipralisant does not appear to be as efficacious as 3 mg/kg ciproxifan at its maximally effective dose . Cipralisant behaves as a partial agonist in a rat brain synaptosome model.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male SHR pups (35–50 g)
Dosage:	0.3~30 mg/kg
Administration:	S.c.
Result:	Significantly enhanced performance of the SHR pups in a dose-related manner at 1 mg/kg.

Animal Model:	Male Sprague-Dawley rats
Dosage:	10 and 30 mg/kg
Administration:	P.o.
Result:	Achieved greater brain exposure and water intake was monitored for 60 min after administration.

体内研究

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male SHR pups (35–50 g)
Dosage:	0.3~30 mg/kg
Administration:	S.c.
Result:	Significantly enhanced performance of the SHR pups in a dose-related manner at 1 mg/kg.

Animal Model:	Male Sprague-Dawley rats
Dosage:	10 and 30 mg/kg
Administration:	P.o.
Result:	Achieved greater brain exposure and water intake was monitored for 60 min after administration.

性状

Solid

溶解性数据

In Vitro:

DMSO : 200 mg/mL (924.56 mM; Need ultrasonic)

配制储备液

浓度溶剂体积质量	1 mg	5 mg	10 mg

1 mM	4.6228 mL	23.1139 mL	46.2278 mL
5 mM	0.9246 mL	4.6228 mL	9.2456 mL
10 mM	0.4623 mL	2.3114 mL	4.6228 mL

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式